Showing results (331-340 of 1,831) with videos related to
Sort By:
Pageof 184
ESMO Open|October 16, 2025
Meta-analysis of surrogate endpoints for overall survival in extensive-stage small-cell lung cancerS Durer, P Fu, Z Chen, et al.ESMO Open|October 8, 2025
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancerF Jacobs, S D'Amico, E Ferraro, et al.ESMO Open|October 3, 2025
NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world dataA Reichinger, A Friedrich, T Lentner, et al.ESMO Open|October 2, 2025
Cyclin-dependent kinase 4/6 inhibitors beyond progression in hormone receptor-positive, HER2-negative advanced breast cancer: a systematic review and meta-analysis (REIGNITE study)L F C de Almeida, L F Leite, V O C Filho, et al.ESMO Open|August 13, 2025
The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinomaP Economopoulou, T Rampias, A Spathis, et al.ESMO Open|August 15, 2025
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)M Hamann, M Christgen, O Gluz, et al.ESMO Open|February 8, 2023
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancerS M Buijs, E Oomen-de Hoop, C L Braal, et al.ESMO Open|February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group networkG G Baldi, A M Frezza, C Biagioni, et al.ESMO Open|January 29, 2026
Tislelizumab plus bevacizumab and XELOX as first-line treatment of MSS/pMMR RAS-mutant metastatic colorectal cancer (TACTIC CRC-02): a phase II studyX Liu, K Ou, X Ma, et al.ESMO Open|February 3, 2026
Incidence and risk factors of brain metastases in radically resected melanoma patients: a large international cohort studyM Mandalà, P Rutkowski, R Patuzzo, et al.Pageof 184